IPCALAB

Ipca Laboratories Share PriceIpca Laboratories

₹780.00
-4.4 (-0.56%)
  • Advice
  • Hold
As on 26 March, 2023 | 20:08 BSE: 524494 NSE: IPCALAB

Ipca Laboratories Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in Ipca Laboratories

Start SIP

Ipca Laboratories Share Price

  • Over 1 Month -3.16%
  • Over 3 Month -9.76%
  • Over 6 Month -10.75%
  • Over 1 Year -22.65%

Ipca Laboratories Key Statistics

P/E Ratio 37.7
PEG Ratio -0.9
Market Cap Cr 19,789
Price to Book Ratio 3.6
EPS 34
Dividend 0.5
Relative Strength Index 33.99
Money Flow Index 24.63
MACD Signal -15.55
Average True Range 15.76

Ipca Laboratories Investment Rating

  • Master Rating:
  • Ipca Laboratories has an operating revenue of Rs. 6,021.79 Cr. on a trailing 12-month basis. An annual revenue growth of 8% is good, Pre-tax margin of 19% is great, ROE of 16% is good. The company has a reasonable debt to equity of 7%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 57 which is a POOR score indicating inconsistency in earnings, a RS Rating of 34 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at E which indicates heavy supply, Group Rank of 80 indicates it belongs to a poor industry group of Medical-Generic Drugs and a Master Score of D is close to being the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Ipca Laboratories Financials
IndicatorDec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 1,4331,4851,4691,168
Operating Expenses Qtr Cr 1,2191,2131,212989
Operating Profit Qtr Cr 214272257179
Depreciation Qtr Cr 57555352
Interest Qtr Cr 10973
Tax Qtr Cr 52777227
Net Profit Qtr Cr 120168144110

Ipca Laboratories Technicals

EMA & SMA

Current Price
₹780.
-4.4 (-0.56%)
  • Bullish Moving Average
  • ___
  • 0
  • Bearish Moving Average
  • ___
  • 16
  • 20 Day
  • 795.34
  • 50 Day
  • 820.13
  • 100 Day
  • 845.3
  • 200 Day
  • 883.12
  • 20 Day
  • 792.92
  • 50 Day
  • 830.31
  • 100 Day
  • 848.76
  • 200 Day
  • 884.98

Ipca Laboratories Resistance and Support

PIVOT
₹785.09
Resistance
First Resistance 790.77
Second Resistance 797.14
Third Resistance 802.82
RSI 33.99
MFI 24.63
MACD Single Line -15.55
MACD -14.4
Support
First Resistance 778.72
Second Resistance 773.04
Third Resistance 766.67

Ipca Laboratories Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 67,689 2,106,482 31.12
Week 121,823 6,423,727 52.73
1 Month 268,393 16,001,576 59.62
6 Month 289,307 14,829,877 51.26

Ipca Laboratories Result Highlights

Ipca Laboratories Synopsis

NSE-Medical-Generic Drugs

Ipca Laboratorie is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company’s Total Operating Revenue is Rs. 5399.36 Cr. and Equity Capital is Rs. 25.37 Cr. for the Year ended 31/03/2022. Ipca Laboratories Ltd. is a Public Limited Listed company incorporated on 19/10/1949 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24239MH1949PLC007837 and registration number is 007837.
Market Cap 19,826
Sales 5,555
Shares in Float 13.70
No of funds 245
Yield 0.51
Book Value 3.59
U/D Vol ratio 0.5
LTDebt / Equity 7
Alpha -0.09
Beta 0.36

Ipca Laboratories

Owner NameDec-22Sep-22Jun-22Mar-22
Promoters 46.29%46.29%46.29%
Mutual Funds 29.79%29.71%29.41%
Insurance Companies 3.76%3.57%3.9%
Foreign Portfolio Investors 10.46%10.57%10.61%
Financial Institutions/ Banks
Individual Investors 7.41%7.44%7.5%
Others 2.29%2.42%2.29%

Ipca Laboratories Management

Name Designation
Mr. Premchand Godha Chairman & M.D & CEO
Mr. Ajit Kumar Jain Joint Managing Director & CFO
Mr. Pranay Godha Executive Director
Mr. Prashant Godha Executive Director
Mr. Anand T Kusre Independent Director
Mr. Dev Parkash Yadava Independent Director
Dr.(Mrs.) Manisha Premnath Independent Director
Mr. Kamal Kishore Seth Independent Director

Ipca Laboratories Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Ipca Laboratories MF Shareholding

Name Amount(cr)
HDFC Balanced Advantage Fund Growth 51042
ICICI Prudential Balanced Advantage Fund Growth 44516
HDFC Mid-Cap Opportunities Fund Growth 35010
Parag Parikh Flexi Cap Regular Growth 29953
ICICI Prudential Value Discovery Fund Growth 27450

Ipca Laboratories FAQs

What is Share Price of Ipca Laboratories ?

Ipca Laboratories share price is ₹780 As on 26 March, 2023 | 19:54

What is the Market Cap of Ipca Laboratories ?

The Market Cap of Ipca Laboratories is ₹19788.9 Cr As on 26 March, 2023 | 19:54

What is the P/E ratio of Ipca Laboratories ?

The P/E ratio of Ipca Laboratories is 37.7 As on 26 March, 2023 | 19:54

What is the PB ratio of Ipca Laboratories ?

The PB ratio of Ipca Laboratories is 3.6 As on 26 March, 2023 | 19:54

Q2FY23

Start Investing Now!

Open Free Demat Account in 5 mins

Enter Valid Mobile Number